Cardarine-25

Cardarine Peptides, also known as GW-501516, is a synthetic drug that was originally developed in the 1990s as a potential treatment for cardiovascular diseases, metabolic disorders, and certain types of cancers. It belongs to a class of chemicals called PPAR agonists (peroxisome proliferator-activated receptor agonists).

However, Cardarine gained popularity in the fitness and bodybuilding community due to its purported ability to increase endurance and fat burning. It was believed to work by activating the PPAR delta pathway, which in turn could increase the expression of genes involved in energy expenditure.

It’s important to note that while Cardarine has been marketed as a performance-enhancing drug, it has not been approved for human use or deemed safe by regulatory authorities such as the FDA. Research on Cardarine has primarily been conducted on animals, with limited human studies. Concerns have been raised about potential side effects and long-term health risks associated with its use.